These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11699207)

  • 21. CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia.
    Pulte D; Olson KE; Broekman MJ; Islam N; Ballard HS; Furman RR; Olson AE; Marcus AJ
    J Transl Med; 2007 May; 5():23. PubMed ID: 17480228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells.
    De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G
    Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
    Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
    Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
    J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ; Melmed S
    Endocrinology; 1999 Apr; 140(4):1559-66. PubMed ID: 10098488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells.
    Ghamlouch H; Darwiche W; Hodroge A; Ouled-Haddou H; Dupont S; Singh AR; Guignant C; Trudel S; Royer B; Gubler B; Marolleau JP
    Oncotarget; 2015 Jul; 6(21):18484-503. PubMed ID: 26050196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta.
    Aderka D; Maor Y; Novick D; Engelmann H; Kahn Y; Levo Y; Wallach D; Revel M
    Blood; 1993 Apr; 81(8):2076-84. PubMed ID: 8386026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New perspectives on the approach to chronic lymphocytic leukemia.
    Goodman MG; Spinosa JC; Saven A; Piro LD; Wormsley S
    Leuk Lymphoma; 1996 Jun; 22(1-2):1-10. PubMed ID: 8724523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
    Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
    Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphotoxin-alpha is an autocrine growth factor for chronic lymphocytic leukemia B cells.
    Kulmburg P; Radke M; Digel W
    Leukemia; 1998 Apr; 12(4):493-8. PubMed ID: 9557606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
    Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
    Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and production of interleukin 10 in human myeloma cell lines.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
    Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.
    Levesque MC; Misukonis MA; O'Loughlin CW; Chen Y; Beasley BE; Wilson DL; Adams DJ; Silber R; Weinberg JB
    Leukemia; 2003 Feb; 17(2):442-50. PubMed ID: 12592345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
    Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
    Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and production of interleukin 4 in B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T; Proctor SJ; Miller S; Dickinson AM
    Leuk Lymphoma; 2001 Aug; 42(4):689-98. PubMed ID: 11697499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
    Mankaï A; Buhé V; Hammadi M; Youinou P; Ghedira I; Berthou C; Bordron A
    Ann N Y Acad Sci; 2009 Sep; 1173():721-8. PubMed ID: 19758221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
    Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
    Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.
    Campbell CL; Jiang Z; Savarese DM; Savarese TM
    Am J Pathol; 2001 Jan; 158(1):25-32. PubMed ID: 11141475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two differentially expressed interleukin-11 receptor genes in the mouse genome.
    Bilinski P; Hall MA; Neuhaus H; Gissel C; Heath JK; Gossler A
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):359-63. PubMed ID: 8973540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.